Nearly 118 million people in Russia receive medical care annually, accounting for 81% of the country’s population, announced Deputy Prime Minister Tatyana Golikova during a strategic session on the national project “New Health Preservation Technologies.” She also highlighted that by 2030, the pharmaceutical and medical industries will require 50,000 specialists and that in 2023, the import of medical devices decreased by 4.5%, and over 60% of the medicines sold in the country are now produced domestically.
According to Golikova’s presentation, the pharmaceutical industry will need 7,200 specialists with higher education and 9,800 with specialized secondary education by 2030. Meanwhile, the medical industry will require 23,900 specialists with higher education and 9,200 with specialized secondary education. “The increased demand for specialists in the medical industry is due to the expansion of critical nomenclature almost fivefold,” she explained.
Golikova noted that 63% of the medications sold in Russia are produced domestically. “Over the past three years, the Russian market has shown growth both in physical and monetary terms. 63% of the medications sold are produced in the country, which means three out of every five packages consumed by citizens are locally made,” she said. The Deputy Prime Minister also clarified that nearly 46% of all medication names, including essential ones, are produced in Russia through a full-cycle process, including substance synthesis. Additionally, a third of all purchased medical devices are of Russian origin.
